Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function

Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function

Cysteinyl leukotrienes (cysLTs) are produced predominantly by cells of the innate immune system, especially basophils, eosinophils, mast cells, and monocytes/macrophages. Notwithstanding potent bronchoconstrictor activity, cysLTs are also proinflammatory consequent to their autocrine and paracrine i...

Full description

Bibliographic Details
Main Authors:	A. J. Theron, H. C. Steel, G. R. Tintinger, C. M. Gravett, R. Anderson, C. Feldman
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2014/608930

Similar Items

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
by: Gregory R. Tintinger, et al.
Published: (2010-01-01)

Cysteinyl-Leukotriene Receptors and Cellular Signals
by: G. Enrico Rovati, et al.
Published: (2007-01-01)

The role of cysteinyl-leukotriene receptors in asthma
by: Hao, Lanping
Published: (2003)

Selective Cysteinyl Leukotriene Receptor Antagonist Modulates Matrix Metalloproteinase Expression in a Mouse Asthma Model
by: Chia-Hsiu, et al.
Published: (2008)

Investigation of the neutrophil-directed anti-inflammatory properties of the cysteinyl leukotriene receptor antagonist, montelukast
by: Lodder, Cornelia Magdalena
Published: (2013)

Regulation of Dendritic Cell Functions against Harmful Respiratory Pathogens by a Cysteinyl Leukotrienes Receptor Antagonist
by: Hiroto Matsuse M.D., Ph.D., et al.
Published: (2012-01-01)

Population-based open-label clinical effectiveness assessment of the cysteinyl leukotriene receptor antagonist pranlukast
by: Gen Tamura, et al.
Published: (2000-01-01)

The Role of Cysteinyl Leukotriene Receptor 2 in Thrombocyte Aggregation
by: Reyna, Julianna
Published: (2015)

Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.
by: Holly R Foster, et al.
Published: (2013-01-01)

Therapeutic Effect of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, on Japanese Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
by: Alper Otunctemur, et al.
Published: (2015-04-01)

Involvement of the cysteinyl-leukotrienes in coronary artery disease
by: Shah, Duniya
Published: (1997)

Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors
by: Anastasiia Gusach, et al.
Published: (2019-12-01)

Studies on the effect of cysteinyl leukotrienes on human T cell differentiation and function
by: Parmentier, Celine
Published: (2013)

Effect of Selective Cysteinyl Leukotriene Receptor Antagonists on Airway Inflammation and Matrix Metalloproteinase Expression in a Mouse Asthma Model
by: Chia-Hsiu Hsu, et al.
Published: (2012-08-01)

Cysteinyl leukotriene metabolism of human eosinophils in allergic disease
by: Jun Miyata, et al.
Published: (2020-01-01)

Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
by: Paolo Gelosa, et al.
Published: (2017-01-01)

Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
by: Francesca Colazzo, et al.
Published: (2017-01-01)

Montelukast treatment (cysteinyl leukotriene receptor antagonist) in a model of food allergy: modifications in lymphatic cell population from rectal mucosa
by: M. Vinuesa, et al.

Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation
by: Yohei Kawai, et al.
Published: (2019-01-01)

Introduction of Leukotriene Receptor Antagonists in Manitoba
by: C Macie, et al.
Published: (2006-01-01)

The role of Cysteinyl leukotriene receptor-1 during experimental helminth infections in murine model
by: Mosala, Paballo Pertunia
Published: (2021)

Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.
by: Cecilia Magnusson, et al.
Published: (2011-01-01)

Expression of cysteinyl leukotriene receptor-1 in pancreatic cancer tissue and its clinical significance
by: MENG Yan, et al.
Published: (2017-01-01)

Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders
by: Glaucia A. Thompson-Souza, et al.
Published: (2017-07-01)

Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation
by: Xianghong Zhou, et al.
Published: (2019-03-01)

Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells.
by: Vinay Kondeti, et al.
Published: (2013-01-01)

Additive effect of cysteinyl leukotriene or thromboxane modifiers to inhaled corticosteroids in asthmatic patients
by: Shigeharu Myou, et al.
Published: (2004-01-01)

Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
by: Lorraine Burke, et al.
Published: (2016-09-01)

Multifaceted Roles of Cysteinyl Leukotrienes in Eliciting Eosinophil Granule Protein Secretion
by: Renata Baptista-dos-Reis, et al.
Published: (2015-01-01)

Role of Leukotriene Receptor Antagonists in Asthma
by: Chih-Hsing Hung
Published: (2012-08-01)

Leukotriene Receptor Antagonists and Related Compounds
by: Sally E Wenzel
Published: (1999-01-01)

High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells
by: Kayleigh Slater, et al.
Published: (2020-10-01)

Cysteinyl leukotriene receptor 2 activation mediates post-myocardial ischemia/reperfusion injury inflammatory processes
by: Ni, NATHAN
Published: (2013)

Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
by: Milanese Manlio, et al.
Published: (2006-07-01)

A Double-Blind Non-inferiority Clinical Study of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Compared with Pranlukast in Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Characterization of a Newly Synthesized Cysteinyl Leukotriene 2 Receptor Selective Antagonist Using Cell Based β-arrestin and Vascular Ear Permeability Assays in Mice
by: YAN, DONG
Published: (2011)

Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease.
by: Elena Nobili, et al.
Published: (2012-01-01)

Saisonale Veränderung der Cysteinyl-Leukotrien Konzentrationen bei Atopikern in den Blutleukozyten
by: Mühlhans, Ulrike
Published: (2009)

Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes
by: Bednarek Andrzej K, et al.
Published: (2009-12-01)